There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apyx Medical (APYX – Research Report) and Better Therapeutics, Inc. (BTTX – Research Report) with bullish sentiments.
Apyx Medical (APYX)
In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Apyx Medical, with a price target of $3.00. The company’s shares closed last Tuesday at $2.97.
According to TipRanks.com, Takkinen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Apyx Medical with a $5.17 average price target.
See today’s best-performing stocks on TipRanks >>
Better Therapeutics, Inc. (BTTX)
In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Better Therapeutics, Inc., with a price target of $1.50. The company’s shares closed last Tuesday at $0.21, close to its 52-week low of $0.14.
According to TipRanks.com, Flaten ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Better Therapeutics, Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $5.25.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on APYX:
